Cargando...
A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human β-Cell Replication and Survival as well as GABA's Ability to Inhibit Inflammatory T Cells
A major goal of T1D research is to develop new approaches to increase β-cell mass and control autoreactive T cell responses. GABA(A)-receptors (GABA(A)-Rs) are promising drug targets in both those regards due to their abilities to promote β-cell replication and survival, as well as inhibit autoreact...
Gardado en:
| Publicado en: | J Diabetes Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413367/ https://ncbi.nlm.nih.gov/pubmed/30937314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5783545 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|